Table 2.
Effect of CsA and CY on humoral and cellular immune responses of turkeys (* the difference between groups treated with CsA or CY and untreated group is significant (p<0.1); ** the difference between groups treated with CsA or CY and untreated group is significant (p<0.05))
| Treatment | Antibody responsea | Mitogenic responseb | 
|---|---|---|
| Trial 1 | ||
| None | 3.20±0.45 | 140.01±101.98 | 
| CsAc | 3.00±0.00 | 61.37±37.80* | 
| CYd | 2.25±0.50** | 35.46±7.37* | 
| Trial 2 | ||
| None | 5.40±2.30 | 60.89±26.63 | 
| CsA | 3.00±1.00 | 21.04±4.82** | 
| CY | 0.00±0.00** | 54.46±24.31 | 
Turkey poults were intramuscularly injected with SRBC cells at 10 days old prior to infection with TCV. Data are expressed as mean±standard deviation (SD) of hemagglutination titers (log2) from five turkey poults in each group at 7 days after injection.
Data are expressed as mean±SD of stimulation index from five turkey poults in each group at 10 days old.
Turkey poults were treated with CsA, 100mg per kg body weight, at 7 days old in trial 1 or 4 days old in trial 2 and every third day thereafter.
Turkey poults were treated with CY, 5mg per turkey poult per day on the first 3 days post-hatching.